The largest database of trusted experimental protocols

31 protocols using pai 1

1

Quantifying Endothelial Secretome Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the quantification of cytokines, chemokines and angiogenic factors secreted by the endothelial cells, Enzyme-Linked Immuno Sorbent Assays (ELISA) were performed using commercially available ELISA antibodies. All reagents were used in accordance to the manufacturer’s specifications. uPA, PDGF-BB, PAI-1, Angiopoietin-2, VEGF, HGF, Il-6, CXCL1, CXCL10, CXCL12, CCL2, CCL5, CCL20, CCL27 (all R&D Systems, Abingdon, UK) and CXCL8 (Sanquin, Amsterdam, The Netherlands). ELISA results are expressed as amount of angiogenic factor/cytokine/chemokine in ng/mL.
+ Open protocol
+ Expand
2

Modulating Immune Responses with Targeted Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNase I (HY‐P72974, MedChemExpress, Monmouth Junction, NJ, USA) was used to degrade NETs and NEi (GW‐311616; HY‐15891, MedChemExpress) was used to inhibit neutrophil elastase. Fedratinib (S2736, Selleck, Houston, TX, USA) was used to inhibit JAK2, C188‐9 (S8605, Selleck) was used to inhibit STAT3, and fisogatinib (BLU‐554; S8503, Selleck) and BLU9931 (A8706, APExBIO, Houston, USA) were used to inhibit FGFR4. Clodronate liposomes (40337ES10, YEASEN Biotechnology, Shanghai, China) was used for macrophage depletion, and diphtheria toxin (D0564, Sigma‐Aldrich, St. Louis, MO, USA) was used for dendritic cell depletion.
Recombinant human FGF19, IL‐1α, CXCL11, MIF and PAI‐1 were purchased from R&D Systems (Minneapolis, MN, USA). Recombinant human IL‐1β, IL‐18, and complement C5a were purchased from Novoprotein (Shanghai, China).
Human FGF19 neutralizing antibody (AF969, R&D Systems), human IL‐1β neutralizing antibody (AF‐201‐NA, R&D Systems), and human complement C5a neutralizing antibody (MAB2037, R&D Systems) were used in this study. Mouse Ly‐6G antibody (16‐5931‐85, eBioscience, San Diego, CA, USA) was used for neutrophil depletion, mouse asialo GM1 antibody (16‐6507‐39, eBioscience) was used for NK cell depletion, and mouse CD20 antibody (152104, Biolegend, San Diego, CA, USA) was used for B cell depletion.
+ Open protocol
+ Expand
3

Measurement of Fibrosis Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of fibrosis biomarkers were measured on EDTA plasma by ELISA or multiplex assay using commercially available kits. HA (Echelon Biosciences, Salt Lake City, UT), LOXL2 (R&D Systems, Minneapolis, Minnesota), and CICP and CIC C1Q (Quidel, San Diego, CA) were measured by ELISA. PAI-1, PCSK9, TGF-β1-3, MMP-2, MMP-9, TIMP-1, CXCL4, Chi3L1 (all R&D Systems, Minneapolis, MN) were measured using Luminex xMAP technology. All analytes except LOXL2 were measured according to the manufacturers’ instructions. For LOXL2, the ELISA plates were coated overnight with capture antibody at room temperature. The plate was blocked with reagent diluent 1 (R&D Systems, Minneapolis, MN) for 1 hour and washed. Plasma was diluted 1:10 in PBS-Tween 10 and added to the plate. After incubating for 2 hours at 37° C and washing, detection antibody was added for 2 hours at 37° C. The plate was washed, streptavidin was added and the plate was incubated for 20 minutes at room temperature. After washing, TMB was added (Sigma-Aldrich Corp., St. Louis, MO), the plate was incubated for 20 minutes at room temperature, and sulfuric acid was added to stop the reaction. The plate was read at 450 nm.
+ Open protocol
+ Expand
4

Cytokine and Angiogenic Factor Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sandwich enzyme-linked immunosorbent assay (ELISA) kits were used to quantify plasma concentrations of proinflammatory cytokines (Leptin, monocyte chemotactic protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1)), angiogenic factors (vascular endothelial growth factor (VEGF) and tissue inhibitor of metalloproteinase-1 (TIMP-1)) and insulin following manufacturers' protocols. Leptin, MCP-1, PAI-1, VEGF and TIMP-1 ELISA kits were obtained from R&D Systems (Minneapolis, MN), and the insulin kit was from Mercodia (Winston-Salem, NC). Samples were read within the linear range of the assay, and the accuracy of the analysis was confirmed by the controls provided in each kit.
+ Open protocol
+ Expand
5

Quantification of Inflammatory Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The commercially available enzyme-linked immunosorbent assay (ELISA) kits were used to measure the levels in pleural effusions or in PMC conditioned medium of thrombin (AssayPro LLC., St. Charles, MO, USA), TNF-α, IL-1β, PAI-1, and tPA (R & D System; Minneapolis, MN, USA) as previously described [20 (link)].
+ Open protocol
+ Expand
6

Endothelial Biomarker Profiling in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treatment effects on 10 biomarkers related to endothelial function were studied in citrated plasma processed from venous blood harvested at baseline, 1-month FU, and prolonged FU. Samples were stored at −80°C in aliquots containing 0.25 mL citrated plasma. Plasma levels of ANGPT2, ANGPTL4, ICAM-1, VCAM-1, ESEL, TM, PAI-1, PAI-2 (R&D Systems, Minneapolis, Minnesota, United States) and VEGF-A (PeproTech, Cranbury, New Jersey, United States) were measured in duplicate by enzyme immunoassays (EIAs), applying commercially available antibodies in a 384 format, and using a combination of a SELMA (Jena, Germany) pipetting robot and a BioTek (Winooski, Vermont, United States) dispenser/washer. Absorption was read at 450 nm with wavelength correction set to 540 nm using an enzyme-linked immunosorbent assay plate reader (Bio-Rad, Hercules, California, United States). Plasma VWF levels were measured by EIAs, as described above with antibodies obtained from Dako (Glostrup, Denmark), using a polyclonal antibody for coat (A0082) and a horseradish peroxidase-conjugated polyclonal antibody for detection (P02256). Parallel-diluted pooled human plasma from 10 random samples was used as standard. Intra- and interassay coefficients of variation were < 10% for all EIAs. Units were ng/mL, except for VEGF (pg/mL) and VWF (AU).
+ Open protocol
+ Expand
7

Biomarkers of Metabolic Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
Morning blood samples were collected from each patient before and after the study following overnight fasting. Serum samples were immediately frozen and stored at −70°C until analysis.
Adiponectin was measured by enzyme-linked immune assay (ELISA) (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions. The levels of interleukin (IL)-6 (Cayman Chemical Company, Ann Arbor, MI, USA), high-sensitivity C-reactive protein (hs-CRP) (Abnova, Taipei City, Taiwan), and plasminogen activator inhibitor (PAI)-1 (R&D Systems) were measured using an ELISA kit.
+ Open protocol
+ Expand
8

Aspirin's Effects on Inflammatory Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mature 3T3-L1 adipocytes were treated with various doses of aspirin and stimulated by 2.5 ng/mL TNF-α (PeproTech, Rocky Hill, NJ, USA) and 1 mg/mL lipopolysaccharide (LPS) (Sigma) in DMEM containing 1% BS for 24 h. Cell culture supernatants were collected and cytokine levels were analyzed by enzyme-linked immunosorbent assay (ELISA). The analytic protocol of cytokines included IL-6, IL-1β, macrophage chemoattractant protein-1 (MCP-1), leptin, adiponectin, plasminogen activator inhibitor-1 (PAI)-1 (R&D, Minneapolis, MN, USA), and vascular endothelial growth factor (VEGF) (PeproTech, Rocky Hill, NJ, USA), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
9

Cytokine Profiling in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture supernatants (48-hours) were analyzed in duplicate by ELISA using kits: PGE2 (multi-species), rat IL-1RA, rat IL-10 (R&D Systems, Minneapolis, MN); FGF7/KGF (BlueGene, Shanghai); MPO (RayBioTech, Norcross, GA); TSG6 (MyBiosource, San Diego, CA). Other cytokines were evaluated on a Luminex (Austin, TX) using rat-specific bead sets: FasL, G-CSF, GM-CSF, IFNγ, IL-4, IL-12p40&p70, LIX, RANTES (Millipore, Billerica, MA); PAI-1, CXCL1, TNFα, IL1α, IL-2, IL-4, IL-6 (R&D Systems).
+ Open protocol
+ Expand
10

Biochemical Measurement of Adipokines and Insulin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available enzyme-linked immunosorbent assay (ELISA) kits were used to perform the biochemical measurements of adipokines and insulin according to the manufacturer’s instructions (visfatin kit was from BioVision; chemerin, PAI-1, resistin, CCL-2, IL-6, IL-8, IL-10 and TNF-α kits were from R&D; leptin, adiponectin and insulin kits were from Thermo Fisher Scientific). The coefficient of variability (CV) for the ELISA kits were shown as follows: visfatin (intra-assay: 4.4–8%; inter-assay: 8.2%), chemerin (intra-assay: 3.9%; inter-assay: 7.3%), PAI-1 (intra-assay: 6.8%; inter-assay: 7%), resistin (intra-assay: 4.7%; inter-assay: 8.4%), CCL-2 (intra-assay: 5%; inter-assay: 5.1%), IL-6 (intra-assay: 2.6%; inter-assay: 4.5%), IL-8 (intra-assay: 4.7–6.7%; inter-assay: 5.8–7.7%), IL-10 (intra-assay: 3.7%; inter-assay: 6.9%), TNF-α (intra-assay: 4.9–7.8%; inter-assay: 4.7%-5.8%), leptin (intra-assay: 3.9%; inter-assay: 5.3%), adiponectin (intra-assay: 3.8%; inter-assay: 5.5%), and insulin (intra-assay: 4.8%-6%; inter-assay: 8.1% to 9%). All measurements were performed in duplicates or triplicates. Seven controls (one blank, two at lower concentrations, two at medium concentrations, and two at higher concentrations) were also quantified in duplicates to check for the reproducibility of measurements and confirm acceptable reproducibility.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!